BeiGene CEO and Key Executive Team

• John V. Oyler

  Co-Founder, Chairman, Chief Executive Officer
• Xiaodong Wang

  Co-Founder, Chairman of Scientific Advisory Board
• Xiaobin Wu

  President, Chief Operating Officer & General Manager of China
• Anita Wu

  Chief Commercial Officer, Greater China
• Angus Grant

  Chief Business Executive
• Julia Wang

  Chief Financial Officer
• Josh Neiman

  SVP, Chief Commercial Officer, North America and Europe
• Jonathan Liu

  Chief Executive, Bio-Island Initiative & Chairman of the Board, BeiGene Guangzhou Biologics, Ltd. Co.
• Jason Radford

  SVP, Strategy & Corporate Development
• Wendy Yan

  SVP, Chief Regulatory Officer
• Melika Davis

  Senior Vice President, Global Head, Clinical Operations
• Graham Hardiman

  Senior Vice President, Global Human Resources
• Bob Mecca

  Senior Vice President, Finance
• Christiane Langer

  Senior Vice President, Global Medical Affairs (Ex-China)
• Kevin Mannix

  Senior Vice President, Investor Relations
• Gary Wang

  VP, Head of HRBP & TA
• Geoff Kim

  Vice President, Applied Innovation
• Nils Eckardt

  Vice President, Medical Affairs Europe
• Lily Liu Yan

  VP of Marketing, Beijing, China
• Lai Wang

  Global Head of R&D
• Claudia Rigamonti

  Country Medical Director, Italy & Balkans
• Chan Lee

  General Counsel
• Dirk Weber

  Executive Director, Medical Affairs, Europe
• Patrik Zintl

  Executive Director, Medical Affairs
• Clare Fisher

  SVP, Business Development, Licensing & M&A
• Jaspreet Jaggi

  SVP and Head, Clinical Portfolio Strategy
• Michael Schoen

  Chief of Staff and Special Advisor to the CEO
• Donald W. Glazer

  Director
• Michael Goller

  Director
• Han Ma

  Chief Safety Officer and SVP, Global Patient Safety
• Ranjeev Krishana

  Director
• Tony Guo

  Global Head of Statistics and Data Science
• Mehrdad Mobasher

  Chief Medical Officer, Hematology
• Thomas Malley

  Director
• Alex Huang

  VP, Head of Cell Therapy
• Michael Nuoqing Yi

  Director
• Chichi Huang

  VP, Head of Biologics
• Mark Lanasa

  SVP, Chief Medical Officer, Solid Tumors
• Mike Liu

  VP, Head of Biology
• Zhirong Shen

  VP, Global Head of Translational Discovery, Research & Medicine
• Zhiwei Wang

  SVP, Research, Head of Chemistry
• Minhong Yan

  VP, Head of the BeiGene Institute
• Anthony Hooper

  Director
• Jurij Petrin

  Head of New Market Development
• Hongyu Qian

  VP, Medical Affairs, Great China
• Adam Roach

  VP and Head of Asia Pacific
• Corsee Sanders

  Director
• Margaret Dugan

  Director
• Eva Yin

  Chief Commercial Officer, Greater China
• Diana Lee Francis

  VP and Global Head, Quality & Regulatory Compliance

Source: beigene.com, beigene.com, beigene.com, beigene.com, beigene.com, beigene.com, beigene.com, beigene.com